Clinical Uses: H1 Histamine Receptor Blockers

 

  •  Motion Sickness:
    • Scopolamine and certain first-generation H1 blockers -- most effective drugs for motion sickness prevention
    • Diphenhydramine and promethazine: greatest effectiveness
    •  Cyclizine (Marezine) and  meclizine: also effective, less sedating
    • Scopolamine and first-generation H1 blockers are more effective in preventing motion sickness when given in combination with ephedrine or amphetamine

return to main menu

  • Nausea and Vomiting (Pregnancy)
    •  H1 blockers are not recommended for use in management of nausea and vomiting associate with pregnancy because:
      • Difficulty in assessment of possible birth defects associated with certain H1 (benedictin) antagonists and known teratogenic effects of others (e.g., doxylamine) in animal models.

return to main menu

 H1 blockers: Toxicity 

  •  Uncommon toxic effects following systemic demonstration:
    • excessive excitation and convulsions in children
    • orthostatic (postural) hypotension
    • Allergic responses
  • Drug allergy -- relatively common, following topical use of H1 antagonists
  • First-generation overdosage: similar to atropine overdosage
  •  Second-generation overdosage: may induce cardiac arrhythmias

return to main menu

Drug-Drug Interactions

  • Second-generation H1 blockers:
    •  Myocardial toxicity:
      •  Toxicity follows combination of terfenadine or astemizole combined with ketoconazole (Nizoral), itraconazole (Sporanox), or macrolide antibiotics (e.g.,erythromycin) because-
      • Q-T (ECG) prolongation
      •  ventricular arrhythmias (potentially fatal)
      • Terfenadine (Seldane)/astemizole (Hismanal) -- contraindicated for:
        • patients taking ketoconazole (Nizoral), itraconazole (Sporanox), macrolide antibiotics, and patients with diminished liver function
      •  Fexofenadine (Allegra), a metabolite of terfenadine (Seldane), is safer. It is possible that terfenadine (Seldane) may be withdrawn (or has been withdrawn recently) from the market given availability of safer alternative medication.

return to main menu

Burkhalter, A, Julius, D.J. and Katzung, B. Histamine, Serotonin and the Ergot Alkaloids (Section IV. Drugs with Important Actions on Smooth Muscle), in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 261-286.
Austen, K. F. Diseases of Immediate Type Hypersensitivity (Section 2: Disorders of Immune-Mediated Injury) In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., and Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp. 1860-1868.